diazoxide and Allergic Encephalomyelitis

diazoxide has been researched along with Allergic Encephalomyelitis in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Biber, K; Espinosa-Parrilla, JF; Mancera, P; Pugliese, M; Sorrosal, G; Virgili, N; Wappenhans, B1
Chanvillard, C; Espinosa-Parrilla, JF; Infante-Duarte, C; Mancera, P; Pugliese, M; Rodríguez, MJ; Virgili, N; Wappenhans, B; Wegner, A1
Espinosa-Parrilla, JF; Gimeno-Bayon, J; Mahy, N; Mancera, P; Pastén-Zamorano, A; Pugliese, M; Rodríguez, MJ; Virgili, N1
Datko, LJ; Kassarich, J; Rosenthale, ME; Schneider, F1

Other Studies

4 other study(ies) available for diazoxide and Allergic Encephalomyelitis

ArticleYear
K(ATP) channel opener diazoxide prevents neurodegeneration: a new mechanism of action via antioxidative pathway activation.
    PloS one, 2013, Volume: 8, Issue:9

    Topics: Animals; Antioxidants; Cell Line; Cell Survival; Cerebellum; Diazoxide; Dose-Response Relationship, Drug; Encephalomyelitis, Autoimmune, Experimental; Female; Hippocampus; Ion Channel Gating; KATP Channels; Mice; Microglia; Motor Neurons; Myelin Sheath; Neurodegenerative Diseases; Neuroprotective Agents; Neurotoxins; NF-E2-Related Factor 2; Oxidative Stress; Protein Transport; Rats; Spinal Cord

2013
Diazoxide attenuates autoimmune encephalomyelitis and modulates lymphocyte proliferation and dendritic cell functionality.
    Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 2014, Volume: 9, Issue:4

    Topics: Animals; Antigens, CD; B7-1 Antigen; B7-2 Antigen; CD4-Positive T-Lymphocytes; CD83 Antigen; Cells, Cultured; Dendritic Cells; Diazoxide; Encephalomyelitis, Autoimmune, Experimental; Female; Histocompatibility Antigens Class II; Immunoglobulins; Lymphocyte Activation; Membrane Glycoproteins; Mice; Spleen

2014
Oral administration of the KATP channel opener diazoxide ameliorates disease progression in a murine model of multiple sclerosis.
    Journal of neuroinflammation, 2011, Nov-02, Volume: 8

    Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Antihypertensive Agents; Cell Line; Diazoxide; Disease Models, Animal; Disease Progression; Encephalomyelitis, Autoimmune, Experimental; Female; Humans; Interferon-gamma; Interleukin-6; KATP Channels; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Microglia; Multiple Sclerosis; Nitrites; Tumor Necrosis Factor-alpha

2011
Chemotherapy of experimental allergic encephalomyelitis (EAE).
    Archives internationales de pharmacodynamie et de therapie, 1969, Volume: 179, Issue:2

    Topics: Allopurinol; Aminocaproates; Analgesics; Animals; Antineoplastic Agents; Azathioprine; Body Weight; Chloroquine; Colchicine; Cortisone; Cyclophosphamide; Cyproheptadine; Diazoxide; Dimethyl Sulfoxide; Encephalomyelitis, Autoimmune, Experimental; Hydrocortisone; Immunosuppressive Agents; Male; Mercaptopurine; Methotrexate; Methyldopa; Nialamide; Oils; Organ Size; Rats; Strychnine; Talc; Thalidomide; Thioguanine; Thiomalates

1969